The current Steering Committee (whose at-large members were elected in February of 2007), voted to formally adopt the use of the title "Board of Directors" in March of 2007.

As stated above, at-large Board members were voted into office in February, (and two additional members were added to the roster in April of 2007). Working Group Representatives are selected and appointed by their respective Working Groups. Current working group representative terms will expire on August 15, 2007. At-large members serve a one-year term beginning at the date they were elected (with the option to be re-elected at the conclusion of their term).

Executive Committee:

Cathy Olufs- President, California *
Raffi Babakhanian- Vice President, New York *
Fred Schaich - Secretary, Oregon *
Ken Fornataro- Treasurer, New York *

At-Large Members:

Rob Camp- Barcelona/ New York *
Steve Garrett, New Mexico *
Eric Goldman Esq., New York *
Patrick Kramme, Arizona *

Working Group Representatives:

Richard Jefferys- Immune Based Therapies (IBT), New York
Morris Jackson- Drug Development Committee (DDC), California

Non-Voting Members:

Edward Rewolinski- ATAC Managing Director, Boston / New York

* At-Large committee member